Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence
Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), and Ainnova Tech, Inc., (Ainnova) a leading healthcare ...
Pharmabiz15h
New investment from the ADDF’s Diagnostics Accelerator leads efforts to develop standardization materials for leading diagnostic biomarker
New investment from the ADDF’s Diagnostics Accelerator leads efforts to develop standardization materials for leading diagnostic biomarker: New York Saturday, November 16, 2024, ...
Morningstar4d
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence
LAS VEGAS, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), and Ainnova Tech, Inc., (Ainnova) a leading ...
Irish Star on MSN10d
Dementia symptoms: First clue of illness can be found in the eyes
A study by the UCSF Weill Institute for Neurosciences found that retinal scans can identify blood vessel changes indicative ...
TMCnet4d
Global Artificial Intelligence (AI) Influence on Healthcare Market Expected to Reach $148 Billion By 2029
as well as diseases unrelated to the retina like cardiovascular disease and potentially even Alzheimer’s with high accuracy and speed using retinal scans. Meanwhile, Ainnova’s next-generation ...
Mena FN4d
Global Artificial Intelligence (AI) Influence On Healthcare Market Expected To Reach $148 Billion By 2029 - Financial News Media
as well as diseases unrelated to the retina like cardiovascular disease and potentially even Alzheimer's with high accuracy and speed using retinal scans. Meanwhile, Ainnova's next-generation ...
Alzheimer's detection could become easier with possible retinal imaging, skin tests
Alzheimer's researchers are widening the scope of biomarkers used to detect Alzheimer's and dementia. In a recent research update, the Alzheimer's Association a ...
EU regulator backs Eisai-Biogen Alzheimer's drug after initial rejection
The European Union's drugs regulator on Thursday recommended approval of Eisai and Biogen's Leqembi for some patients with ...
Los Angeles Times6d
Opinion: Too many older Americans are getting tested for Alzheimer’s
An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of Alzheimer’s ... a PET scan or a spinal fluid test.